These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8026885)

  • 1. Metastasis of mouse T lymphoma cells is controlled by the level of major histocompatibility complex class I H-2Dk antigens.
    VandenDriessche T; Geldhof A; Bakkus M; Toussaint-Demylle D; Brijs L; Thielemans K; Verschueren H; De Baetselier P
    Int J Cancer; 1994 Jul; 58(2):217-25. PubMed ID: 8026885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introduction of the interferon gamma gene into mouse T lymphoma cells with low MHC class I-expression results in selective induction of H-2Dk and concomitant enhanced metastasis.
    Geldhof AB; VandenDriessche T; Opdenakker G; De Baetselier P
    Cancer Immunol Immunother; 1996 Jul; 42(6):329-38. PubMed ID: 8830735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumorigenicity of mouse T lymphoma cells is controlled by the level of major histocompatibility complex class I H-2Kk antigens.
    VandenDriessche T; Bakkus M; Toussaint-Demylle D; Thielemans K; Verschueren H; De Baetselier P
    Clin Exp Metastasis; 1994 Jan; 12(1):73-83. PubMed ID: 8287623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of altered antigen processing on H-2Dk mediated NK inhibition in a murine T lymphoma model.
    Van Ginderachter J; Raes G; Devoogdt N; De Baetselier F; Geldhof A
    Adv Exp Med Biol; 1998; 451():237-40. PubMed ID: 10026878
    [No Abstract]   [Full Text] [Related]  

  • 5. NK sensitivity, H-2 expression and metastatic potential: analysis of H-2Dk gene transfected fibrosarcoma cells.
    Gopas J; Rager-Zisman B; Har-Vardi I; Hammerling GJ; Bar-Eli M; Segal S
    J Immunogenet; 1989; 16(4-5):305-13. PubMed ID: 2639905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to NK and metastatic potential of fibrosarcoma cells is associated with products encoded by the H-2D region.
    Rager-Zisman B; Aboud M; Gopas J; Har-Vardi I; Hämmerling GJ; Segal S
    Semin Cancer Biol; 1991 Oct; 2(5):329-36. PubMed ID: 1773048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of B7-1 by highly metastatic mouse T lymphomas induces optimal natural killer cell-mediated cytotoxicity.
    Geldhof AB; Raes G; Bakkus M; Devos S; Thielemans K; De Baetselier P
    Cancer Res; 1995 Jul; 55(13):2730-3. PubMed ID: 7540948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenization of a murine T-cell lymphoma via transfection with interferon-gamma.
    Raes G; Geldhof A; Vanden Driessche T; Opdenakker G; Sibille C; De Baetselier P
    Leukemia; 1995 Oct; 9 Suppl 1():S121-7. PubMed ID: 7475304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association in the expression of Kirsten-ras oncogene and the major histocompatibility complex class I antigens in fibrosarcoma tumor cell variants exhibiting different metastatic capabilities.
    Alon Y; Hammerling GJ; Segal S; Bar-Eli M
    Cancer Res; 1987 May; 47(10):2553-7. PubMed ID: 3552201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic capacity of cloned T10 sarcoma cells that differ in H-2 expression: inverse relationship to their immunogenic potency.
    Katzav S; Segal S; Feldman M
    J Natl Cancer Inst; 1985 Aug; 75(2):307-18. PubMed ID: 3894752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction of the H-2Dk gene into a class I-negative tumor cell line confers interferon-gamma inducibility upon the silent endogenous H-2Kk gene.
    Rosenthal LA; Klyczek KK; Blank KJ
    Cell Immunol; 1992 Nov; 145(1):43-55. PubMed ID: 1423645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple effects of transfection with interleukin 2 and/or interferon gamma on the behavior of mouse T lymphoma cells.
    Geldhof AB; Van Ginderachter J; Vandersteen P; Raes G; De Baetselier P
    Clin Exp Metastasis; 1998 Jul; 16(5):447-59. PubMed ID: 10091940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nonclassical major histocompatibility complex molecule Qa-2 protects tumor cells from NK cell- and lymphokine-activated killer cell-mediated cytolysis.
    Chiang EY; Henson M; Stroynowski I
    J Immunol; 2002 Mar; 168(5):2200-11. PubMed ID: 11859106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
    J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between MHC class I antigen expression and malignancy of murine T lymphoma variants.
    Vanden Driessche T; Verschueren H; De Baetselier P
    Invasion Metastasis; 1990; 10(2):65-85. PubMed ID: 2307562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfection of beta 2-microglobulin restores IFN-mediated protection from natural killer cell lysis in YAC-1 lymphoma variants.
    Ljunggren HG; Sturmhöfel K; Wolpert E; Hämmerling GJ; Kärre K
    J Immunol; 1990 Jul; 145(1):380-6. PubMed ID: 2113557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of the H-2Dk MHC class-I antigen and tissue inhibitor of metalloproteinases in metastatic and nonmetastatic T-10 fibrosarcoma cells.
    Har-Vardi I; Gopas J; Rager-Zisman B; Hammerling GJ; Segal S; Aboud M
    Invasion Metastasis; 1992; 12(5-6):301-8. PubMed ID: 1298741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of the metastatic potential of line 1 lung carcinoma cells: opposite effects of class I antigen induction by interferons versus DMSO or gene transfection.
    Cerosaletti KM; Blieden TM; Harwell LW; Welsh KM; Frelinger JG; Lord EM
    Cell Immunol; 1990 May; 127(2):299-310. PubMed ID: 1691690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells.
    Karlhofer FM; Ribaudo RK; Yokoyama WM
    Nature; 1992 Jul; 358(6381):66-70. PubMed ID: 1614533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blastocyst MHC, a putative murine homologue of HLA-G, protects TAP-deficient tumor cells from natural killer cell-mediated rejection in vivo.
    Tajima A; Tanaka T; Ebata T; Takeda K; Kawasaki A; Kelly JM; Darcy PK; Vance RE; Raulet DH; Kinoshita K; Okumura K; Smyth MJ; Yagita H
    J Immunol; 2003 Aug; 171(4):1715-21. PubMed ID: 12902470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.